BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12
1424 results:

  • 1. Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.
    Elez E; Cubillo A; Alfonso PG; Middleton MR; Chau I; Alkuzweny B; Alcasid A; Zhang X; Van Cutsem E
    BMC Cancer; 2024 Apr; 24(1):446. PubMed ID: 38600471
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Expression of immune checkpoints PD-L1, ctla4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
    Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
    Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy.
    Shen W; Li Y; Yang Z; Li W; Cao Y; Liu Y; Wang Z; Pei R; Xing C
    J Nanobiotechnology; 2024 Apr; 22(1):154. PubMed ID: 38581017
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Exploring the clinical significance of IL-38 correlation with PD-1, ctla-4, and FOXP3 in colorectal cancer draining lymph nodes.
    Yuan L; Tan Z; Huang J; Chen F; Hambly BD; Bao S; Tao K
    Front Immunol; 2024; 15():1384548. PubMed ID: 38533512
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Occurrence of colorectal cancer After a Negative Colonoscopy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Scotti GB; Iannone I; DE Padua C; Crocetti D; Fiori G; Sapienza P; Fiori E; Avenia S; Lamazza A
    In Vivo; 2024; 38(2):523-530. PubMed ID: 38418112
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Lactate modulates RNA splicing to promote ctla-4 expression in tumor-infiltrating regulatory T cells.
    Ding R; Yu X; Hu Z; Dong Y; Huang H; Zhang Y; Han Q; Ni ZY; Zhao R; Ye Y; Zou Q
    Immunity; 2024 Mar; 57(3):528-540.e6. PubMed ID: 38417442
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluating CD4 and Foxp3 mRNA Expression in Tissue Specimens of Celiac Disease and colorectal cancer Patients.
    Asri N; Nazemalhosseini Mojarad E; Taleghani MY; Houri H; Saeedi Niasar M; Rezaei-Tavirani M; Jahani-Sherafat S; Shahbazkhani A; Nikzamir A; Ehsani Ardakani MJ; Khodadost M; Rostami-Nejad M
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):647-652. PubMed ID: 38415552
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Unveiling the immune symphony: decoding colorectal cancer metastasis through immune interactions.
    He R; Huang S; Lu J; Su L; Gao X; Chi H
    Front Immunol; 2024; 15():1362709. PubMed ID: 38415252
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB.
    Fróes RSB; Andrade AR; Faria MAG; de Souza HSP; Parra RS; Zaltman C; Dos Santos CHM; Bafutto M; Quaresma AB; Santana GO; Luporini RL; de Lima Junior SF; Miszputen SJ; de Souza MM; Herrerias GSP; Junior RLK; do Nascimento CR; Féres O; de Barros JR; Sassaki LY; Saad-Hossne R
    Sci Rep; 2024 Feb; 14(1):4314. PubMed ID: 38383742
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Increased CpG methylation at the CDH1 locus in inflamed ileal mucosa of patients with Crohn disease.
    de Ponthaud C; Abdalla S; Belot MP; Shao X; Penna C; Brouquet A; Bougnères P
    Clin Epigenetics; 2024 Feb; 16(1):28. PubMed ID: 38355645
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Neoadjuvant Immunotherapy With Ipilimumab Plus Nivolumab in Mismatch Repair Deficient/Microsatellite Instability-High colorectal cancer: A Preliminary Report of Case Series.
    Pan T; Yang H; Wang WY; Rui YY; Deng ZJ; Chen YC; Liu C; Hu H
    Clin Colorectal Cancer; 2024 Mar; 23(1):104-110. PubMed ID: 38336555
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Causal linkage between type 2 diabetes mellitus and inflammatory bowel disease: an integrated Mendelian randomization study and bioinformatics analysis.
    Xiao X; Wu X; Yi L; You F; Li X; Xiao C
    Front Endocrinol (Lausanne); 2024; 15():1275699. PubMed ID: 38313367
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [A Case of Clostridium difficile Enteritis with Ileostomy for Rectal cancer Surgery].
    Takahashi H; Hamasaki S; Tanaka H; Sakamoto Y; Kawasaki R; Mitsui N; Morikita T; Oda H
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1647-1649. PubMed ID: 38303370
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota.
    Zhang H; Shi Y; Lin C; He C; Wang S; Li Q; Sun Y; Li M
    Front Immunol; 2023; 14():1338918. PubMed ID: 38288125
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Implementation of a robotic surgical practice in inflammatory bowel disease.
    Ferrari L; Nicolaou S; Adams K
    J Robot Surg; 2024 Jan; 18(1):57. PubMed ID: 38281204
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia.
    Gurbatri CR; Radford GA; Vrbanac L; Im J; Thomas EM; Coker C; Taylor SR; Jang Y; Sivan A; Rhee K; Saleh AA; Chien T; Zandkarimi F; Lia I; Lannagan TRM; Wang T; Wright JA; Kobayashi H; Ng JQ; Lawrence M; Sammour T; Thomas M; Lewis M; Papanicolas L; Perry J; Fitzsimmons T; Kaazan P; Lim A; Stavropoulos AM; Gouskos DA; Marker J; Ostroff C; Rogers G; Arpaia N; Worthley DL; Woods SL; Danino T
    Nat Commun; 2024 Jan; 15(1):646. PubMed ID: 38245513
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy.
    Qin G; Bai F; Hu H; Zhang J; Zhan W; Wu Z; Li J; Fu Y; Deng Y
    Mol Med; 2024 Jan; 30(1):13. PubMed ID: 38243170
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Role of visceral fat on postoperative complications and relapse in patients with Crohn's disease after ileocecal resection: Is it overrated?
    Schineis CHW; Pozios I; Boubaris K; Weixler B; Kamphues C; Margonis GA; Kreis ME; Strobel RM; Beyer K; Seifarth C; Luitjens J; Kaufmann D; Lauscher JC
    Int J Colorectal Dis; 2024 Jan; 39(1):20. PubMed ID: 38240842
    [TBL] [Abstract] [Full Text] [Related]  

  • 19.
    Battaglin F; Baca Y; Millstein J; Yang Y; Xiu J; Arai H; Wang J; Ou FS; Innocenti F; Mumenthaler SM; Jayachandran P; Kawanishi N; Lenz A; Soni S; Algaze S; Zhang W; Khoukaz T; Roussos Torres E; Seeber A; Abraham JP; Lou E; Philip PA; Weinberg BA; Shields AF; Goldberg RM; Marshall JL; Venook AP; Korn WM; Lenz HJ
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212126
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer.
    Mahadevia H; Uson Junior PLS; Wang J; Borad M; Babiker H
    Expert Opin Pharmacother; 2024; 25(1):79-90. PubMed ID: 38193476
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 72.